Chemical and Biological Defense Program - Advanced Development

Abstract

This program element (PE) resources Advanced Technology Development across the Understand, Protect, Mitigate, and Enabling Investments portfolios. Chemical and Biological Defense Program (CBDP) investments provide an integrated, layered capability to enable Countering Weapons of Mass Destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The Projects in this PE demonstrate technologies supporting the transition to advanced component development for physical capabilities, which cover chemical and biological (CB) detection, situational awareness and effects modeling, and protection and hazard mitigation. FY24 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual Projects include: - Understand (UN3): Demonstration of enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for biosurveillance in pathogen detection and diagnosis, produce biological diagnostic arrays and reagents and diagnostic device platforms. - Protect (PT3): Production of pretreatment candidates for bacterial, viral, and toxin threats. - Mitigate (MT3): Production of therapeutic candidates for bacterial, viral, and toxin threats. - Enabling Investments (EN3): Demonstrations of CB defense technologies, including biological detection, chemical detection, and decontamination, including non-traditional agents. Continued efforts to enhance the military operational capability, concepts of operation, and WMD elimination. - Emerging Threats (ET3): identify and develop scientific solutions or to modernize capabilities that allow for a more rapid response to emerging threats. - Chemical Biological Defense (CB3), Non-Traditional Agents (NTA) Defense (NT3), Techbase Medical Defense (TM3), and Technology Transition (TT3) are no longer active FY24 Projects due to budget restructuring. CBDP Science and Technology (S&T) Applied Research Performers: U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), and Department of Energy Laboratories such as Pacific Northwest National Laboratory (PNNL), among others. The intent is to maintain strategic partnerships with the DoD Service communities & the interagency for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Work conducted under this PE will transition to and will provide risk reduction for Advanced Component Development and Prototypes (PE 0603884BP) and System Development and Demonstration (PE 0604384BP) activities.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2024
Source ID
0603384BP_3_0400_PB_2024
Change Summary Explanation
Funding: FY 2022 (-$3.365 Million): Below threshold reprogramming to support Advanced Emerging Threat Defense efforts in Advanced Component Development & Prototypes, Budget Activity 4, and reprogrammed prior year execution balances to RDT&E Management Support, Budget Activity 6 in support of the Departments higher priorities. FY 2022 (-$2.764 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2023 (-$0.182 Million): Congressional General Reductions to support Federally Funded Research and Development Centers (FFRDCs). FY 2023 (-$17.000 Million): Congressional Directed Reductions. FY 2023 (+$5.000 Million): Congressional Add for broad spectrum small molecule anti-viral development. FY 2024 (+$19.002 Million): Increase for Chemical Warfare Defense Prophylaxis and Therapeutics and CBRN Warning and Decision Support efforts (+$12.033 Million), to expand early warning through wastewater surveillance capabilities (+$5.700 Million), and Departmental inflation rate adjustments (+$1.269 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Autonomy
  • Biomedical
  • Ground and Sea Platforms

DTIC Thesaurus Topics

  • Biological Factors
  • Biosensors
  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemistry
  • Covid-19
  • Data Analysis
  • Detection
  • Health Services
  • Materials Testing
  • Mathematical Models
  • Medical Personnel
  • Synthetic Biology
  • Test And Evaluation
  • Test Methods
  • Vaccines
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents